BALA CYNWYD, Pa., May 10, 2022 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Biohaven Pharmaceutical Holding Company Ltd. (NYSE - BHVN)
Under the terms of the agreement, Pfizer will acquire all outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash. Biohaven common shareholders, including Pfizer, will also receive 0.5 of a share of New Biohaven, a new publicly traded company that will retain Biohaven’s non-CGRP development stage pipeline compounds, per Biohaven common share. The investigation concerns whether the Biohaven Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Pfizer is paying too little for the Company.
Additional information can be found at https://www.brodskysmith.com/cases/biohaven-pharmaceutical-holding-company-ltd-nyse-bhvn/.
Tiga Acquisition Corp. (NYSE - TINV)
Under the terms of the agreement, Tiga, a special purpose acquisition company, will combine with Grindr, the #1 social network for the LGBTQ+ community, and result in Grindr becoming a publicly-listed company. Under the terms of the agreement, Tiga shareholders will retain ownership of only 14% of the combined company. The investigation concerns whether the Tiga Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of ownership interest in the combined company.
Additional information can be found at https://www.brodskysmith.com/cases/tiga-acquisition-corp-nyse-tinv/.
Lakeshore Acquisition I Corp. (Nasdaq - LAAA)
Under the terms of the agreement, Lakeshore, a special purpose acquisition company, will combine with ProSomnus Holdings Inc. (“ProSomnus”), a maker of patient-preferred medical devices for the treatment of obstructive sleep apnea, and result in ProSomnus becoming a publicly-listed company. Under the terms of the agreement, Lakeshore shareholders will retain ownership of only 32% of the combined company. The investigation concerns whether the Lakeshore Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of ownership interest in the combined company.
Additional information can be found at https://www.brodskysmith.com/cases/lakeshore-acquisition-corp-nasdaq-laaa/.
Silicon Motion Technology Corporation (Nasdaq – SIMO)
Under the terms of the agreement, Silicon Motion will be acquired by MaxLinear, Inc. (Nasdaq - MXL). Under the terms of the merger agreement, each American Depositary Share (“ADS”) of Silicon Motion, which represents four ordinary shares of Silicon Motion, will receive $93.54 in cash and 0.388 shares of MaxLinear common stock, for total per ADS consideration of $114.34 (based on MaxLinear’s May 4, 2022 closing price). The investigation concerns whether the Silicon Motion Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether MaxLinear is paying too little for the Company.
Additional information can be found at https://www.brodskysmith.com/cases/silicon-motion-technology-corporation-nasdaq-simo/
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
Source:
Brodsky & Smith LLC2022 GlobeNewswire, Inc., source Press Releases
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. 
